Question

I am a breastfeeding mother and i want to know if it is safe to use Genotropin? Is Genotropin safe for nursing mother and child? Does Genotropin extracts into breast milk? Does Genotropin has any long term or short term side effects on infants? Can Genotropin influence milk supply or can Genotropin decrease milk supply in lactating mothers?

Genotropin lactation summary

Genotropin usage has low risk in breastfeeding
  • DrLact safety Score for Genotropin is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of Genotropin may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that Genotropin may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of Genotropin low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using Genotropin We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About Genotropin usage in lactation

We are working on a comment for this product.

Answer by DrLact: About Genotropin usage in lactation

Limited data indicate that exogenous Genotropin does not increase normal breastmilk concentrations of growth hormone and that no adverse effects are experienced by the breastfed infants of mothers who receive Genotropin. Small studies by one group of investigators found that milk output increases from 19% to 36% after a 7-day course of Genotropin. Because mothers were not given extensive breastfeeding support in these studies, the usefulness of the drug as a galactogogue in mothers given adequate breastfeeding support is not known. Galactogogues should never replace evaluation and counseling on modifiable factors that affect milk production.[1] Based on theoretical considerations, the manufacturer of Zomacton 5 mg recommends avoiding the use of the diluent, which contains benzyl alcohol, for lactating women. Instead use preservative-free normal saline as a diluent and discard any remaining drug.

Genotropin Side Effects in Breastfeeding

Among 34 infants in 3 studies who were breastfed during maternal use of subcutaneous Genotropin for 7 days during lactation, none were reported to have adverse reactions to the drug. Dosages were 0.05 (n = 5), 0.1 (n = 13) or 0.2 (n = 16) international units daily.[2][4][5]

Genotropin Possible Effects in Breastfeeding

In a double-blind study, normal, lactating women were given Genotropin 0.1 international units/kg daily subcutaneously for 7 days or placebo. The 8 women given Genotropin increased their average milk output by 157 mL daily from the baseline of 835 mL daily. Placebo-treated patients experienced an increase from 855 mL daily to 955 mL daily. The difference in increase between the two groups was statistically significant. Milk content did not change with therapy.[2] Ten mothers of premature infants born at an average of 30.6 weeks gestation (range 26 to 34 weeks) were given subcutaneous Genotropin to increase their milk supply at an average of 39.7 days postpartum. The dosage was 0.2 international units daily, up to a maximum of 16 international units daily, for 7 days. The amount of milk produced on day 8 was compared to the average amount extracted on the 2 days prior to therapy. Average milk production increased from 139 mL daily to 175 mL daily compared to a statistically nonsignificant increase from 93 mL daily to 102 mL daily in the placebo group. Many of the mothers in the placebo group, but none in the Genotropin group, had decreases in production during the study.[5] The differences in baseline milk production between the 2 groups might have affected the response to Genotropin and the study did not report the changes, if any, in the proportion of infant nutrition from breastmilk. The same group studied 16 lactating mothers with normal healthy infants; 5 of the women were having lactational problems. Women received either subcutaneous Genotropin 0.05, 0.1 or 0.2 international units daily for 7 days. The two low-dose groups (n = 10) had a 4.7% increase in their milk output; mothers in the high-dose group (n = 6) increased their milk output by 36% from the baseline of 297 mL daily output. Three of the mothers who received the higher dose were able to completely or nearly completely breastfeed their infants.[4] None of the above studies reported providing mothers with information on breastfeeding technique or any other type of breastfeeding support. In a study designed to determine the genetic effects of growth hormone administration, 5 nursing mothers were given Genotropin (Nortitropin) 0.1 mg/kg by subcutaneous injection once daily at about 800 am for 3 days. No difference was found in the average suckling-induced serum prolactin levels on day 1 (baseline) and day 4. Average milk volume did not change over the 4-day study period. The study found that DNA synthesis and cell cycle genes were induced, but no changes were observed in the expression of milk synthesis genes. The authors speculated that the duration of the study might have been too short to observe induction of milk synthesis genes.[6]
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.